胸腺肿瘤

Girard N, Ruffini E, Marx A, et al. Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(suppl 5):v40-v55.全文  摘要

Phan AT, Öberg K, Choi J, et al. NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the thorax (includes lung and thymus). Pancreas. 2010;39:784-98.全文  摘要

National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: thymomas and thymic carcinomas [internet publication].全文

1. Hsu CH, Chan JK, Yin CH, et al. Trends in the incidence of thymoma, thymic carcinoma, and thymic neuroendocrine tumor in the United States. PLoS One. 2019;14(12):e0227197.全文  摘要

2. Girard N, Ruffini E, Marx A, et al. Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(suppl 5):v40-v55.全文  摘要

3. Detterbeck FC. Clinical value of the WHO classification system of thymoma. Ann Thorac Surg. 2006;81:2328-34.全文  摘要

4. Shimosato Y, Mukai K. Tumors of the mediastinum. In: Rosai J, Sobin LH, eds. Atlas of tumor pathology. Washington, DC: Armed Forces Institute of Pathology; 1997:93-115.

5. Travis W, Brambilla E, Burke A, et al. Tumours of the thymus. In: WHO classification of tumours of the lung, pleura, thymus and heart. 4th ed. Lyon, France: IARC Press; 2015:184-298.

6. Marx A, Chan JKC, Chalabreysse L, et al. The 2021 WHO classification of tumors of the thymus and mediastinum: what Is new in thymic epithelial, germ cell, and mesenchymal tumors? J Thorac Oncol. 2022 Feb;17(2):200-13.全文  摘要

7. Detterbeck F, Parsons A. Thymic tumors: a review of current diagnosis, classification, and treatment. In: Patterson GA, Cooper JD, Deslauriers J, et al, eds. Thoracic and esophageal surgery, 3rd edition. Philadelphia, PA: Elsevier; 2008:1589-614.

8. Detterbeck FC, Parsons AM. Thymic tumors. Ann Thorac Surg. 2004 May;77(5):1860-9.全文  摘要

9. Bolodár A, Török O, Szabó M, et al. Ruling out fetal Sanfilippo's syndrome (mucopolysaccharidosis IIIA) in the first trimester of pregnancy [in Hungarian]. Orv Hetil. 1989 Jan 29;130(5):233-4. 摘要

10. Suadjian J, Enriquez P, Silverstein MN, et al. The spectrum of diseases associated with thymoma: coincidence or syndrome? Arch Intern Med. 1974;154:374-379. 摘要

11. Cugell DW, Kamp DW. Asbestos and the pleura: a review. Chest. 2004;125:1103-1117. 摘要

12. Okumura M, Ohta M, Tateyama H, et al. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer. 2002 Feb 1;94(3):624-32.全文  摘要

13. Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg. 2003;75:878-885. 摘要

14. Filosso PL, Actis Dato GM, Ruffini E, et al. Multidisciplinary treatment of advanced thymic neuroendocrine carcinoma (carcinoid): report of a successful case and review of the literature. J Thorac Cardiovasc Surg. 2004;127:1215-1219. 摘要

15. Wightman SC, Shrager JB. Non-myasthenia gravis immune syndromes and the thymus: is there a role for thymectomy? Thorac Surg Clin. 2019 May;29(2):215-25. 摘要

16. Zhao J, Bhatnagar V, Ding L, et al. A systematic review of paraneoplastic syndromes associated with thymoma: treatment modalities, recurrence, and outcomes in resected cases. J Thorac Cardiovasc Surg. 2020 Jul;160(1):306-314.e14.全文  摘要

17. Carter BW, Marom EM, Detterbeck FC. Approaching the patient with an anterior mediastinal mass: a guide for clinicians. J Thorac Oncol. 2014 Sep;9(9 suppl 2):S102-9.全文  摘要

18. Phan AT, Öberg K, Choi J, et al. NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the thorax (includes lung and thymus). Pancreas. 2010;39:784-98.全文  摘要

19. Kattach H, Hasan S, Clelland C, et al. Seeding of stage I thymoma into the chest wall 12 years after needle biopsy. Ann Thorac Surg. 2005 Jan;79(1):323-4.全文  摘要

20. Nagasaka T, Nakashima N, Nunome H. Needle tract implantation of thymoma after transthoracic needle biopsy. J Clin Pathol. 1993 Mar;46(3):278-9.全文  摘要

21. Byrd CT, Trope WL, Bhandari P, et al. Positron emission tomography/computed tomography differentiates resectable thymoma from anterior mediastinal lymphoma. J Thorac Cardiovasc Surg. 2022 Apr 1:S0022-5223(22)00367-1. 摘要

22. Drachman DB. Myasthenia gravis. N Engl J Med. 1994;330:1797-1810. 摘要

23. Wudel LJ Jr, Nesbitt JC. Superior vena cava syndrome. Curr Treat Options Oncol. 2001 Feb;2(1):77-91. 摘要

24. Marom EM. Imaging thymoma. J Thorac Oncol. 2010;5(suppl 4):296S-303S. 摘要

25. Inaoka T, Takahashi K, Mineta M, et al. Thymic hyperplasia and thymus gland tumors: differentiation with chemical shift MR imaging. Radiology. 2007;243:869-876. 摘要

26. Shin KE, Yi CA, Kim TS, et al. Diffusion-weighted MRI for distinguishing non-neoplastic cysts from solid masses in the mediastinum: problem-solving in mediastinal masses of indeterminate internal characteristics on CT. Eur Radiol. 2014 Mar;24(3):677-84. 摘要

27. Kitami A, Sano F, Ohashi S, et al. The usefulness of positron-emission tomography findings in the management of anterior mediastinal tumors. Ann Thorac Cardiovasc Surg. 2017 Feb 20;23(1):26-30.全文  摘要

28. Luzzi L, Campione A, Gorla A, et al. Role of fluorine-flurodeoxyglucose positron emission tomography/computed tomography in preoperative assessment of anterior mediastinal masses. Eur J Cardiothorac Surg. 2009 Sep;36(3):475-9.全文  摘要

29. Amin M, Edge B, Greene F, et al; American Joint Commission on Cancer. AJCC cancer staging manual. 8th ed. New York, NY: Springer International Publishing; 2017.

30. Howard FM Jr, Lennon VA, Finley J, et al. Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis. Ann N Y Acad Sci. 1987 Aug;505(1):526-38. 摘要

31. Zekeridou A, McKeon A, Lennon VA. Frequency of synaptic autoantibody accompaniments and neurological manifestations of thymoma. JAMA Neurol. 2016 Jul 1;73(7):853-9.全文  摘要

32. Maher MM, Shepard JA. Imaging of thymoma. Semin Thorac Cardiovasc Surg. 2005;17:12-19. 摘要

33. Masaoka A, Monden Y, Nakahara K, et al. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981;48:2485-2492. 摘要

34. Masaoka A, Yamakawa Y, Niwa H, et al. Thymectomy and malignancy. Eur J Cardiothorac Surg. 1994;8:251-253. 摘要

35. Masaoka A. Staging system of thymoma. J Thorac Oncol. 2010;5(suppl 4):304S-312S. 摘要

36. Cancer Care Ontario. Surgical, radiation, and systemic treatments of patients with thymic epithelial tumours. March 2022 [internet publication].全文

37. Ettinger DS, Akerley W, Bepler G, et al; National Comprehensive Cancer Network. Thymic malignancies. J Natl Compr Canc Netw. 2010;8:1302-1315.全文  摘要

38. Khorfan R, Bharat A, Odell DD. Management and long-term outcomes of advanced stage thymoma in the United States. Ann Thorac Surg. 2021 Jan;111(1):223-30.全文  摘要

39. Park S, Park IK, Kim YT, et al. Comparison of neoadjuvant chemotherapy followed by surgery to upfront surgery for thymic malignancy. Ann Thorac Surg. 2019 Feb;107(2):355-62.全文  摘要

40. Yamada Y, Yoshino I, Nakajima J, et al. Surgical outcomes of patients with stage III thymoma in the Japanese nationwide database. Ann Thorac Surg. 2015 Sep;100(3):961-7.全文  摘要

41. Leuzzi G, Rocco G, Ruffini E, et al. Multimodality therapy for locally advanced thymomas: a propensity score-matched cohort study from the European Society of Thoracic Surgeons Database. J Thorac Cardiovasc Surg. 2016 Jan;151(1):47-57.e1.全文  摘要

42. Korst RJ, Bezjak A, Blackmon S, et al. Neoadjuvant chemoradiotherapy for locally advanced thymic tumors: a phase II, multi-institutional clinical trial. J Thorac Cardiovasc Surg. 2014 Jan;147(1):36-44, 46.e1.全文  摘要

43. Davenport E, Malthaner RA. The role of surgery in the management of thymoma: a systematic review. Ann Thorac Surg. 2008;86:673-684. 摘要

44. Nakagawa K, Yokoi K, Nakajima J, et al. Is thymomectomy alone appropriate for stage I (T1N0M0) thymoma? Results of a propensity-score analysis. Ann Thorac Surg. 2016 Feb;101(2):520-6.全文  摘要

45. Voulaz E, Veronesi G, Infante M, et al. Radical thymectomy versus conservative thymomectomy in the surgical treatment of thymic malignancies. J Thorac Dis. 2018 Jul;10(7):4127-4136.全文  摘要

46. Tseng YC, Hsieh CC, Huang HY, et al. Is thymectomy necessary in nonmyasthenic patients with early thymoma? J Thorac Oncol. 2013 Jul;8(7):952-8.全文  摘要

47. Nakagawa K, Asamura H, Sakurai H, et al. Does the mode of surgical resection affect the prognosis/recurrence in patients with thymoma? J Surg Oncol. 2014 Mar;109(3):179-83. 摘要

48. Gu Z, Fu J, Shen Y, et al. Thymectomy versus tumor resection for early-stage thymic malignancies: a Chinese Alliance for Research in Thymomas (ChART) retrospective database analysis [in Chinese]. Zhongguo Fei Ai Za Zhi. 2016 Jul 20;19(7):459-64. 摘要

49. Narm KS, Lee CY, Do YW, et al. Limited thymectomy as a potential alternative treatment option for early-stage thymoma: a multi-institutional propensity-matched study. Lung Cancer. 2016 Nov;101:22-7. 摘要

50. Voulaz E, Perroni G, Russo A, et al. Thymomectomy versus complete thymectomy in early-stage non-myasthenic thymomas: a multicentric propensity score-matched study. Interact Cardiovasc Thorac Surg. 2022 Jun 15;35(1):ivac167.全文  摘要

51. Yang CJ, Hurd J, Shah SA, et al. A national analysis of open versus minimally invasive thymectomy for stage I to III thymoma. J Thorac Cardiovasc Surg. 2020 Aug;160(2):555-567.e15.全文  摘要

52. Friedant AJ, Handorf EA, Su S, et al. Minimally invasive versus open thymectomy for thymic malignancies: systematic review and meta-analysis. J Thorac Oncol. 2016 Jan;11(1):30-8.全文  摘要

53. Manoly I, Whistance RN, Sreekumar R, et al. Early and mid-term outcomes of trans-sternal and video-assisted thoracoscopic surgery for thymoma. Eur J Cardiothorac Surg. 2014 Jun;45(6):e187-93.全文  摘要

54. Sakamaki Y, Oda T, Kanazawa G, et al. Intermediate-term oncologic outcomes after video-assisted thoracoscopic thymectomy for early-stage thymoma. J Thorac Cardiovasc Surg. 2014 Oct;148(4):1230-7.e1.全文  摘要

55. Marulli G, Comacchio GM, Schiavon M, et al. Comparing robotic and trans-sternal thymectomy for early-stage thymoma: a propensity score-matching study. Eur J Cardiothorac Surg. 2018 Sep 1;54(3):579-84.全文  摘要

56. Geraci TC, Ferrari-Light D, Pozzi N, et al. Midterm results for robotic thymectomy for malignant disease. Ann Thorac Surg. 2021 May;111(5):1675-81.全文  摘要

57. Marcuse F, Hochstenbag M, De Baets MHV, et al. Robotic thymectomy for thymomas: a retrospective follow-up study in the Netherlands. Ann Thorac Surg. 2022 Nov;114(5):1886-94.全文  摘要

58. Li XK, Xu Y, Cong ZZ, et al. Comparison of the progression-free survival between robot-assisted thymectomy and video-assisted thymectomy for thymic epithelial tumors: a propensity score matching study. J Thorac Dis. 2020 Aug;12(8):4033-43.全文  摘要

59. Shen C, Li J, Li J, et al. Robot-assisted thoracic surgery versus video-assisted thoracic surgery for treatment of patients with thymoma: a systematic review and meta-analysis. Thorac Cancer. 2022 Jan;13(2):151-61.全文  摘要

60. Mangi AA, Wright CD, Allan JS, et al. Adjuvant radiation therapy for stage II thymoma. Ann Thorac Surg. 2002;74:1033-1037. 摘要

61. Korst RJ, Kansler AL, Christos PJ, et al. Adjuvant radiotherapy for thymic epithelial tumors: a systematic review and meta-analysis. Ann Thorac Surg. 2009;87:1641-1647. 摘要

62. Falkson CB, Vella ET, Ellis PM, et al. Surgical, radiation, and systemic treatments of patients with thymic epithelial tumors: a clinical practice guideline. J Thorac Oncol. 2022 Nov;17(11):1258-75.全文  摘要

63. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: thymomas and thymic carcinomas [internet publication].全文

64. Giannopoulou A, Gkiozos I, Harrington KJ, et al. Thymoma and radiation therapy: a systematic review of medical treatment. Expert Rev Anticancer Ther. 2013;13:759-766. 摘要

65. Chun SG, Rimner A, Amini A, et al. American radium society appropriate use criteria for radiation therapy in the multidisciplinary management of thymic carcinoma. JAMA Oncol. 2023 Jul 1;9(7):971-80. 摘要

66. Venuta F, Rendina EA, Longo F, et al. Long-term outcome after multimodality treatment for stage III thymic tumors. Ann Thorac Surg. 2003;76:1866-1872. 摘要

67. Huang J, Rizk NP, Travis WD, et al. Feasibility of multimodality therapy including extended resections in stage IVA thymoma. J Thorac Cardiovasc Surg. 2007;134:1477-1484. 摘要

68. Loehrer PJ, Jiroutek M, Aisner S, et al. Combined etoposide, ifosfamide and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial. Cancer. 2001;91:2010-2015. 摘要

69. Riely GJ, Huang J. Induction therapy for locally advanced thymoma. J Thorac Oncol. 2010;5(suppl 4):323S-326S. 摘要

70. Lemma GL, Lee JW, Aisner SC, et al. Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma. J Clin Oncol. 2011 May 20;29(15):2060-5.全文  摘要

71. Wright CD, Choi NC, Wain JC, et al. Induction chemoradiotherapy followed by resection for locally advanced Masaoka stage III and IVA thymic tumors. Ann Thorac Surg. 2008;85:385-389. 摘要

72. Loehrer PJ Sr, Chen M, Kim K, et al. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J Clin Oncol. 1997;15:3093-3099. 摘要

73. Wright CD, Wain JC, Wong DR, et al. Predictors of recurrence in thymic tumors: importance of invasion, World Health Organization histology and size. J Thorac Cardiovasc Surg. 2005;130:1413-1421. 摘要

74. Huang J, Rizk NP, Travis WD. Comparison of patterns of relapse in thymic carcinoma and thymoma. J Thorac Cardiovasc Surg. 2009;138:26-31. 摘要

75. Schmitt J, Loehrer PJ. The role of chemotherapy in advanced thymoma. J Thorac Oncol. 2010;5(suppl 4):357S-360S. 摘要

76. Palmieri G, Buonerba C, Ottaviano M, et al. Capecitabine plus gemcitabine in thymic epithelial tumors: final analysis of a Phase II trial. Future Oncol. 2014 Nov;10(14):2141-7. 摘要

77. Zucali PA, De Pas T, Palmieri G, et al. Phase II study of everolimus in patients with thymoma and thymic carcinoma previously treated with cisplatin-based chemotherapy. J Clin Oncol. 2018 Feb 1;36(4):342-9.全文  摘要

78. Thomas A, Rajan A, Berman A, et al. Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial. Lancet Oncol. 2015 Feb;16(2):177-86. 摘要

79. Sato J, Satouchi M, Itoh S, et al. Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trial. Lancet Oncol. 2020 Jun;21(6):843-50. 摘要

80. Wright CD. Pleuropneumonectomy for the treatment of Masaoka stage IVA thymoma. Ann Thorac Surg. 2006;82:1234-1239. 摘要

81. Eng TY, Thomas CR. Radiation therapy in the management of thymic tumors. Semin Thorac Cardiovasc Surg. 2005;17:32-40. 摘要

82. Lucchi M, Mussi A. Surgical treatment of recurrent thymomas. J Thorac Oncol. 2010;5(suppl 4):348S-351S. 摘要

83. Cho J, Kim HS, Ku BM, et al. Pembrolizumab for patients with refractory or relapsed thymic epithelial tumor: an open-label phase II trial. J Clin Oncol. 2019 Aug 20;37(24):2162-70. 摘要

84. Giaccone G, Kim C, Thompson J, et al. Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study. Lancet Oncol. 2018 Mar;19(3):347-55. 摘要

85. Skeie GO, Apostolski S, Evoli A, et al. Guidelines for treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol. 2010;17:893-902. 摘要

86. Okereke IC, Kesler KA, Morad MH, et al. Prognostic indicators after surgery for thymoma. Ann Thorac Surg. 2010 Apr;89(4):1071-7; discussion 1077-9.全文  摘要

87. Rena O, Papalia E, Maggi G, et al. World Health Organization histologic classification: an independent prognostic factor in resected thymomas. Lung Cancer. 2005 Oct;50(1):59-66. 摘要

88. Kondo K, Yoshizawa K, Tsuyuguchi M, et al. WHO histologic classification is a prognostic indicator in thymoma. Ann Thorac Surg. 2004 Apr;77(4):1183-8.全文  摘要

89. Yokoyama S, Miyoshi H. Thymic tumors and immune checkpoint inhibitors. J Thorac Dis. 2018 May;10(suppl 13):S1509-15.全文  摘要

90. Rajan A, Heery CR, Thomas A, et al. Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma. J Immunother Cancer. 2019 Oct 21;7(1):269.全文  摘要

91. Kang SY, Lee JS, Choi JC, Kang JH. Myasthenia gravis appearing after thymectomy: a case report and review of the literature. J Clin Neurol. 2007;3:158-160.全文  摘要

92. Welsh JS, Wilkins KB, Green R, et al. Association between thymoma and second neoplasms. JAMA. 2000;283:1142-1143. 摘要